Hansa Biopharma AB
Contacts
Share:
Subscribe:

IdeS vial

Fri, Apr 11, 2014 08:30 CET

IdeS vial

Transplantation Orphan Drug enzyme kidney Rare Disease IdeS Sensitized Desensitization IgG-degrading enzyme of Streptococcus pyogenes IgG-degrading

Medium resolution

Original resolution

Contacts

Hansa Biopharma AB
Scheelevägen 22 22363 Lund, Sweden
+46 (0) 461 656 70
http://www.hansabiopharma.com
info@hansabiopharma.com

Subscribe

Related Releases

Phase II IdeS-study initiated in Uppsala Wed, Jul 09, 2014 08:00 CET

Hansa Medical to present IdeS at the 2014 World Transplant Congress in San Francisco, July 27 Tue, Jul 01, 2014 08:00 CET

Swedish Medical Products Agency approves Hansa Medical’s clinical Phase II-study application with IdeS Tue, May 06, 2014 08:00 CET